Bone Morphogenetic Protein for the Healing of Tibial Fracture: A Meta-Analysis of Randomized Controlled Trials.

Abstract

PURPOSE:

To review the evidence from RCTs on clinical outcomes and benefit of acute tibial fracture and nonunion treated with and without BMPs.

MATERIAL:

We searched multiple databases (MEDLINE, EMABSE, BIOSIS and Cochrane central) as well as reference lists of articles and contacted authors. Evaluated outcomes included union rate, revision rate, hardware failure and infection. The weighted and standard mean difference (WMD and SMD) or the relative risk (RR) was calculated for continuous or dichotomous data respectively. The quality of the trial was assessed, and meta-analyses were performed with the Cochrane Collaboration's REVMAN 5.0 software.

RESULTS:

Eight RCTs involving 1113 patients were included. For acute tibial fracture, BMP group was associated with a higher rate of union (RR, 1.16; 95% CI, 1.04 to 1.30) and a lower rate of revision (RR, 0.68; 95% CI, 0.54 to 0.85) compared with control group. No significant differences were found in rate of hardware failure and infection. The pooled RR for achieving union for tibial fracture nonunion was 0.98 (95% CI, 0.86 to 1.13). There was no significant difference between the two groups in the rate of revision (RR, 0.48; 95% CI, 0.13 to 1.85) and infection (RR, 0.61; 95% CI, 0.37 to 1.02).

CONCLUSION:

Study on acute tibial fractures suggests that BMP is more effective that controls, for bone union and for decreasing the rate of surgical revision to achieve union. For the treatment of tibial fracture nonunion, BMP leads to similar results to as autogenous bone grafting. Finally, well-designed RCTs of BMP for tibial fracture treatment are also needed.

• Authors: Jiezhi Dai, Li Li, Chaoyin Jiang, Chunyang Wang, Hua Chen, Yimin Chai
• Journal: PloS one (PLoS One) Vol. 10 Issue 10 Pg. e0141670 ( 2015) ISSN: 1932-6203 [Electronic] United States
• PMID: 26509264 (Publication Type: Journal Article, Meta-Analysis)

Chemical References

• Bone Morphogenetic Proteins

Topics

• Bone Morphogenetic Proteins (therapeutic use)
• Fracture Healing
• Fractures, Ununited (complications, therapy)
• Humans
• Odds Ratio
• Publication Bias
• Randomized Controlled Trials as Topic
• Tibial Fractures (complications, therapy)
• Treatment Outcome